网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
CO2激光治疗皮肤鳞状细胞癌的疗效观察
作者:杨蓉弟  李二龙 
单位:四川大学华西医院 皮肤科, 四川 成都 610041
关键词:皮肤鳞状细胞癌 CO2激光 
分类号:R739.5
出版年·卷·期(页码):2020·39·第四期(505-507)
摘要:

目的:探究CO2激光治疗对皮肤鳞状细胞癌的疗效。方法:以我院皮肤科2016年8月至2017年7月收治的90例皮肤鳞状细胞癌患者作为研究对象,随机分为对照组与观察组,每组45例。对照组患者根据病情给予常规治疗,包括手术治疗、药物控制等;观察组患者在常规治疗的基础上给予CO2激光治疗。比较两组患者皮肤鳞状细胞癌总缓解率、皮损消失时间、皮损缩小50%时间、皮肤坏死率及复发率等。结果:观察组患者皮肤鳞状细胞癌的缓解率显著高于对照组患者,且皮损消失时间、皮损缩小50%时间显著短于对照组,皮肤坏死率及复发率优于对照组,差异均具有统计学意义(均P<0.05)。结论:CO2激光治疗能够显著抑制皮肤鳞状细胞癌的复发,降低皮损部位的坏死率,提高总体有效程度,可作为皮肤鳞状细胞癌的有效治疗手段。

Objective: To explore the effects of CO2 laser treatment on skin squamous cell carcinoma. Methods: 90 patients with squamous cell carcinoma of the dermatology admitted to our department of dermatology from August 2016 to July 2017 were randomly divided into control group and observation group, with 45 patients in each group. Control group receivedconventional treatment, including surgery, drug control, while observation group received CO2 laser treatment on the basis of conventional treatment. Two groups were compared with total remission rate,lesions disappeared time and the time of 50% lesion reduction, along with skin necrosis rate and recurrence rate. Results: The total remission rate of skin squamous cell carcinoma in the observation group was significantly higher than that in the control group, andthe disappearance time and 50% reduction time of skin lesions were significantly less than those in the control group, moreover the skin necrosis rate and recurrence rate were better than those in the control group(P<0.05). Conclusion: CO2 laser treatment can significantly inhibit the recurrence of skin squamous cell carcinoma, reduce the necrosis rate of skin lesions, and improve the overall effectiveness, suggesting that CO2 laser treatment can be used as a treatment for skin squamous cell carcinoma and improve the overall effect of clinical treatment.

参考文献:

[1] 刘盛秀,沈颂科,陈静,等.钬激光联合光动力治疗头面部难治性基底细胞癌和鳞状细胞癌疗效评价[J].中国麻风皮肤病杂志,2017,33(8):457- 460.
[2] 岳超,王焱,方方.头颈部皮肤鳞状细胞癌的外科治疗进展[J].国际皮肤性病学杂志,2014,40(5):335-338.
[3] SCHMUTZ J L.Squamous cell carcinoma following photodynamic therapy[J].Ann Dermatol Venereol,2015,142(6-7):463-464.
[4] 吴迪,陈斌,时素英,等.585 nm Q开关脉冲激光、强脉冲光及长脉宽Nd:YAG激光治疗皮肤血管性疾病临床疗效比较[J].临床皮肤科杂志,2010,39(12):793-795.
[5] 武忠弼、杨光华.中华外科病理学[M].北京:人民卫生出版社,2002:2212.
[6] 李庆.皮肤鳞状细胞癌p16、CyclinD1、pRb蛋白表达与临床病理特征的关系[J].医学理论与实践,2018,32(2):177- 179.
[7] ROLLAKANTI K,ANAND S,MAYTIN E V.Topical calcitriol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models[J].Proc SPIE Int Soc Opt Eng,2015,9308:93080Q.
[8] 郝玉琴,刘侠,康淑霞,等.Survivin-shRNA对A431皮肤鳞状细胞癌抑制作用的实验研究[J].中国现代医学杂志,2018,28(28):1-7.
[9] PENG J,FENG W,LUO X,et al.A clinical trial using attrition combined with 5-aminolevulinic acids based photodynamic therapy in treating squamous cell carcinoma[J].Med Sci Monit,2017,23(3):1347- 1354.
[10] JI J,ZHANG Y,CHEN W R,et al.DC vaccine generated by ALAPDT- induced immunogenic apoptotic cells for skin squamous cell carcinoma[J].Oncoimmunology,2015,5(6):e1072674.
[11] 王文鑫,王晓彦.皮肤鳞状细胞癌及基底细胞癌的治疗进展[J].内蒙古医学杂志,2008,40(11):1346-1349.
[12] 郝玉琴,康春义,张鑫,等.人A431皮肤鳞状细胞癌中丝裂原活化蛋白激酶/细胞外信号调节激酶信号通路对P53的调节作用[J].中国现代医学杂志,2016,26(1):24- 29.
[13] 张鲜英,刘毅,肖斌,等.皮肤鳞状细胞癌的外科治疗[J].临床肿瘤学杂志,2012,17(12):1105-1107.
[14] 许学文,岑瑛,石建林.头面部皮肤鳞癌的治疗[C]//2005中国修复重建外科论坛论文汇编.南宁:广西医科大学第一附属医院,2005:1004-1006.
[15] 龚业青,丘小珊,罗育武,等.CO2激光联合ALA-光动力疗法治疗皮肤鳞癌临床分析[C]//中华医学会第十八次全国皮肤性病学术年会论文汇编.北京:中华医学会,2012:447.
[16] 罗敏,石磊,张付贺,等.激光免疫疗法对多发性皮肤鳞状细胞癌小鼠的抗肿瘤效应研究[J].中华皮肤科杂志,2016,49(9):621-625.
[17] 刘星野.激光治疗皮肤鳞癌[C]//第四届全国激光医学联合学术交流大会论文摘要.北京:中华医学会,1998:244.
[18] 李金燕,张宇.1例腮腺原发性鳞状细胞癌的临床病理分析[J].现代医学,2016,44(3):342-344.
[19] GONDIVKAR S M,GADBAIL A R,CHOUDHARY M G,et al.Photodynamic treatment outcomes of potentially-malignant lesions and malignancies of the head and neck region:A systematic review[J].J Investig Clin Dent,2018,9(1):e12270.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 754543 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541